Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? - Wikidata - awgldk - TriplyDB

Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?

Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?

http://www.wikidata.org/entity/Q37075834

about

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs).Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals.

P2860

Q50145685-A78A574D-75A8-412F-9950-9706EABAA210 Q54230120-3BB3D12B-EE51-48AA-9A8C-6638CE7CEE03

P2860

Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?

http://www.wikidata.org/entity/Q37075834

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?

@en

Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?

@nl

type

label

Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?

@en

Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?

@nl

prefLabel

Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?

@en

Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?

@nl

P1433

Q37075834-9F7B77E9-22BA-48E3-86B2-2C5ECA150F7A

P1476

Q37075834-BB33568C-1947-40CA-97BA-F4821257A796

P2093

Q37075834-040E730D-8427-4EBF-8B04-B5AE9AA7D38B

Q37075834-0E77DD85-B32E-412A-AF1D-023BC8DF3496

Q37075834-1FD4973E-64BB-4617-ABF1-15FABBAAB037

Q37075834-2756F33F-C181-4695-B450-F26282CB0C08

Q37075834-3CD1EE1D-0BBD-42B7-9A41-1949FD900633

Q37075834-488BB465-01FD-41E7-9937-070E0DEF6420

Q37075834-4F320DB7-2355-4FC9-9E96-9457EFCEB735

Q37075834-5584D2BE-23E2-45DE-9C64-48EAF73C9308

Q37075834-56D1508D-7C41-4CC5-8819-BFDB8104651E

Q37075834-6CE4E53C-F172-4489-8DA0-58A233C4030E

P2860

Q37075834-020A8186-01D9-4129-8569-FD3589F9E7B8

Q37075834-138CC146-4330-48F9-B465-A9E6A08797B1

Q37075834-17CB05E4-C8C3-45C3-9779-50D2D7F8893F

Q37075834-1BA51327-E3FE-44F6-8325-60ABD4941E86

Q37075834-2795FCA3-FDC9-4384-8111-2A2FF52D70FD

Q37075834-29A5517A-8D6E-49F3-8192-B04DC6B4A8CD

Q37075834-2C400E1C-A63E-417E-BC0E-7182968CC1BC

Q37075834-310E5243-CAD9-4BAD-8604-58DF7279A697

Q37075834-3C0B21F3-DEE0-4B23-9213-E26A9442AB25

Q37075834-40167D5B-E847-40B5-B968-913ADFA31D86

P304

Q37075834-4086314C-BA2F-4679-82FA-138ED9F588DA

P31

Q37075834-872075D1-8725-4104-8B8F-F0081CE9DB2E

P356

Q37075834-678E3D2B-5D20-4332-9207-ECD815B08894

P433

Q37075834-F720739B-9D1B-4823-A4BD-C0037F92FBD3

P478

Q37075834-DDBCB699-E870-4844-A1D8-32EC5114B9E4

P50

Q37075834-EA2769FE-28B8-4951-B49E-A7DA449058F0

P577

Q37075834-C5612567-25E1-4AE1-8244-67713C956BDC

P698

Q37075834-2C038DE4-62D1-40FE-B7AD-86B1C7C02DFE

P932

Q37075834-F3F1AF4E-91FA-4029-AD80-B8415D5425EF

P356

P1433

World journal of hepatology

P1476

Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?

@en

P2093

Alessio Strazzulla

http://www.w3.org/2001/XMLSchema#string

Alfredo Focà

http://www.w3.org/2001/XMLSchema#string

Carlo Torti

http://www.w3.org/2001/XMLSchema#string

Chiara Costa

http://www.w3.org/2001/XMLSchema#string

Concetta Di Fatta

http://www.w3.org/2001/XMLSchema#string

Eleonora Palella

http://www.w3.org/2001/XMLSchema#string

Elio Gulletta

http://www.w3.org/2001/XMLSchema#string

Francesca Giancotti

http://www.w3.org/2001/XMLSchema#string

Giorgio Fuiano

http://www.w3.org/2001/XMLSchema#string

Giorgio Settimo Barreca

http://www.w3.org/2001/XMLSchema#string

P2860

Neutrophil Gelatinase Associated Lipocalin (NGAL) - a biomarker of renal dysfunction in patients with liver cirrhosis: Do we have enough proof?

Model for End-stage Liver Disease

Hepatitis C infection in hemodialysis patients: A review

Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection

Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock.

Urinary neutrophil gelatinase-associated lipocalin: a useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients

Management of patients with hepatitis C infection and renal disease.

Hepatitis C virus induced endothelial inflammatory response depends on the functional expression of TNFα receptor subtype 2

Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels

Neutrophil Gelatinase-Associated Lipocalin: A New Marker of Renal Function in C-Related End Stage Liver Disease

P304

815-824

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4254/WJH.V8.I19.815

http://www.w3.org/2001/XMLSchema#string

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Coppolino

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27429717

http://www.w3.org/2001/XMLSchema#string

P932

4937169

http://www.w3.org/2001/XMLSchema#string